Bioaraba Health Research Institute Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2019
NCT04400630
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bioaraba | Bioaraba Health Research Institute | BIOARABA HRI